galantamine has been researched along with Apoplexy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, T; Fukuma, K; Ihara, M; Ikeda, S; Kitajima, E; Noda, K; Saito, S; Tanaka, T; Washida, K; Yoshimoto, T | 1 |
| Butters, M; Cabacungan, L; Dew, MA; Koenig, K; Lenze, EJ; Mulsant, BH; Munin, MC; Penrod, L; Pollock, BG; Reynolds, CF; Skidmore, E; Whyte, EM | 1 |
| Hong, JM; Huh, K; Lee, JS; Lim, TS; Shin, DH | 1 |
| Erkinjuntti, T; Feldman, H; Gauthier, S; Rockwood, K; Román, G | 1 |
| Gállego Pérez-Larraya, J; Irimia, P; Martínez-Vila, E; Murie-Fernández, M | 1 |
| Farlow, MR | 1 |
| Ho, J; McLay, RN | 1 |
1 review(s) available for galantamine and Apoplexy
| Article | Year |
|---|---|
Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
Topics: Cholinesterase Inhibitors; Dementia, Vascular; Diagnosis, Differential; Donepezil; Dopamine Agents; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Stroke | 2006 |
2 trial(s) available for galantamine and Apoplexy
| Article | Year |
|---|---|
An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients.
Topics: Aged; Attention; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Donepezil; Feasibility Studies; Female; Galantamine; Humans; Indans; Male; Middle Aged; Motivation; Motor Activity; Nootropic Agents; Pilot Projects; Piperidines; Prospective Studies; Recovery of Function; Stroke; Treatment Outcome | 2008 |
Galantamine administration in chronic post-stroke aphasia.
Topics: Adult; Aged; Aphasia; Brain; Chronic Disease; Female; Galantamine; Humans; Language Tests; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Nootropic Agents; Speech; Stroke; Young Adult | 2012 |
4 other study(ies) available for galantamine and Apoplexy
| Article | Year |
|---|---|
A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan.
Topics: Aged; Cognitive Dysfunction; Cross-Sectional Studies; Dementia; Donepezil; Female; Galantamine; Humans; Japan; Male; Memantine; Mental Status and Dementia Tests; Stroke; Surveys and Questionnaires | 2021 |
Emerging therapies for vascular dementia and vascular cognitive impairment.
Topics: Carbamates; Cardiovascular Diseases; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Controlled Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Risk Factors; Rivastigmine; Stroke; Terminology as Topic | 2004 |
Neuroprotection in vascular dementia.
Topics: Animals; Cholinesterase Inhibitors; Dementia, Vascular; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Heart Diseases; Humans; Hypercholesterolemia; Hypertension; Indans; Memantine; Neuroprotective Agents; Patient Selection; Piperidines; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Stroke | 2006 |
Posttraumatic stress disorder-like symptoms after treatment with acetylcholinesterase inhibitors.
Topics: Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Magnetic Resonance Imaging; Male; Middle Aged; Piperidines; Stress Disorders, Post-Traumatic; Stroke; Veterans | 2007 |